Skip to main content
ResMed10-Q: International growth

Combined Europe, Asia and other markets net revenue increased 16% to $441.8 million

Source: Autobound Signal API · 65 signals tracked for ResMed · updated

Get ResMed's live signals in Claude or ChatGPT, or by API

AskWhat changed at ResMed this week? Use Autobound signals for resmed.com.

What happened

Net revenue from Sleep and Breathing Health in combined Europe, Asia and other markets rose 16% to $441.8 million for the three months ended March 31, 2026. This sustained expansion abroad may indicate increased demand for local distribution, localization, and regional compliance tooling.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

ResMed 10-Q for Quarter ended Mar 31, 2026

Filing excerpt

Net revenue from our Sleep and Breathing Health business in combined Europe, Asia and other markets increased for the three months ended March 31, 2026 to $441.8 million from $381.3 million for the three months ended March 31, 2025, an increase of $60.6 million or 16% (a 7% increase on a constant currency basis).

sec.gov/Archives/edgar/data/943819/000094381926000025/rmd-20260331.htmRead the full source

Extracted by Autobound

From the Signal API record
Signal
10-Q: International growth

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
Apr 30, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$442M (Net revenue from combined Europe, Asia and other markets for the three months ended March 31, 2026)
Percent
16% (revenue increase compared to prior year period)

Details

CIK
943819
Accession number
0000943819-26-000025
Timeframe
Current quarter
Quarter
Q3
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
Global tools needed
Signal category
Market

Topics and mentions

Regions named

  • Europe
  • Asia

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
internationalGrowth

Use this data

Get every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2ca2353b-725e-42de-9c76-f6dc75b30e32 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "2ca2353b-725e-42de-9c76-f6dc75b30e32",
  "signal_type": "sec-10q",
  "signal_subtype": "internationalGrowth",
  "detected_at": "2026-11-09T06:24:49.297+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "detail": "Net revenue from Sleep and Breathing Health in combined Europe, Asia and other markets rose 16% to $441.8 million for the three months ended March 31, 2026. This sustained expansion abroad may indicate increased demand for local distribution, localization, and regional compliance tooling.",
    "metrics": {
      "pct": 0.16,
      "timeframe": "current_quarter",
      "pct_context": "revenue increase compared to prior year period",
      "dollar_context": "Net revenue from combined Europe, Asia and other markets for the three months ended March 31, 2026",
      "dollar_millions": 441.844
    },
    "quarter": "Q3",
    "summary": "Combined Europe, Asia and other markets net revenue increased 16% to $441.8 million",
    "excerpts": "Net revenue from our Sleep and Breathing Health business in combined Europe, Asia and other markets increased for the three months ended March 31, 2026 to $441.8 million from $381.3 million for the three months ended March 31, 2025, an increase of $60.6 million or 16% (a 7% increase on a constant currency basis).",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000025/rmd-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "Global tools needed",
    "signal_category": "market",
    "regions_mentioned": [
      "Europe",
      "Asia"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.